-
Je něco špatně v tomto záznamu ?
Recent-onset dilated cardiomyopathy associated with Borrelia burgdorferi infection
P. Kuchynka, T. Palecek, S. Havranek, I. Vitkova, E. Nemecek, R. Trckova, D. Berenová, D. Krsek, J. Podzimkova, M. Fikrle, BA. Danek, A. Linhart,
Jazyk angličtina Země Německo
Typ dokumentu klinické zkoušky kontrolované, časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2005-02-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-02-01 do Před 1 rokem
- MeSH
- antibakteriální látky aplikace a dávkování MeSH
- bakteriální endokarditida diagnóza farmakoterapie mikrobiologie MeSH
- Borrelia burgdorferi izolace a purifikace MeSH
- ceftriaxon aplikace a dávkování MeSH
- dilatační kardiomyopatie diagnóza farmakoterapie mikrobiologie MeSH
- injekce intravenózní MeSH
- kardiotonika aplikace a dávkování MeSH
- kombinovaná farmakoterapie metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- lymeská nemoc diagnóza farmakoterapie mikrobiologie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky kontrolované MeSH
- práce podpořená grantem MeSH
BACKGROUND: Several recent small studies have suggested a causal link between Lyme disease and dilated cardiomyopathy (DCM) by demonstrating the presence of the Borrelia burgdorferi (Bb) genome in the myocardium of patients with recent-onset DCM. The aim of this study was to further investigate the effect of targeted antibiotic treatment of Bb-related recent-onset DCM in a larger cohort of patients. PATIENTS AND METHODS: We performed endomyocardial biopsy (EMB) in 110 individuals (53 ± 11 years, 34 women) with recent-onset unexplained DCM, and detected the Bb genome in 22 (20 %) subjects. Bb-positive patients were subsequently treated with intravenous ceftriaxone for 21 days in addition to conventional heart failure medication. RESULTS: At the 1-year follow-up, a significant improvement in left ventricular (LV) ejection fraction (26 ± 6 vs. 44 ± 12 %; p < 0.01) and a decrease in LV end-diastolic (69 ± 7 vs. 63 ± 11 mm; p < 0.01) and end-systolic (61 ± 9 vs. 52 ± 4 mm; p < 0.01) diameters were documented. Moreover, a significant improvement in heart failure symptoms (NYHA class 3.4 ± 0.6 vs. 1.5 ± 0.7; p < 0.01) was also observed. CONCLUSION: Targeted antibiotic treatment of Bb-related recent-onset DCM in addition to conventional heart failure therapy is associated with favorable cardiac remodeling and improvement of heart failure symptoms.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020832
- 003
- CZ-PrNML
- 005
- 20240911144731.0
- 007
- ta
- 008
- 160722s2015 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00059-015-4308-1 $2 doi
- 024 7_
- $a 10.1007/s00059-015-4308-1 $2 doi
- 035 __
- $a (PubMed)25939436
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Kuchynka, Petr $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic. International Clinical Research Center, St. Anne's University Hospital in Brno, Brno, Czech Republic.
- 245 10
- $a Recent-onset dilated cardiomyopathy associated with Borrelia burgdorferi infection / $c P. Kuchynka, T. Palecek, S. Havranek, I. Vitkova, E. Nemecek, R. Trckova, D. Berenová, D. Krsek, J. Podzimkova, M. Fikrle, BA. Danek, A. Linhart,
- 520 9_
- $a BACKGROUND: Several recent small studies have suggested a causal link between Lyme disease and dilated cardiomyopathy (DCM) by demonstrating the presence of the Borrelia burgdorferi (Bb) genome in the myocardium of patients with recent-onset DCM. The aim of this study was to further investigate the effect of targeted antibiotic treatment of Bb-related recent-onset DCM in a larger cohort of patients. PATIENTS AND METHODS: We performed endomyocardial biopsy (EMB) in 110 individuals (53 ± 11 years, 34 women) with recent-onset unexplained DCM, and detected the Bb genome in 22 (20 %) subjects. Bb-positive patients were subsequently treated with intravenous ceftriaxone for 21 days in addition to conventional heart failure medication. RESULTS: At the 1-year follow-up, a significant improvement in left ventricular (LV) ejection fraction (26 ± 6 vs. 44 ± 12 %; p < 0.01) and a decrease in LV end-diastolic (69 ± 7 vs. 63 ± 11 mm; p < 0.01) and end-systolic (61 ± 9 vs. 52 ± 4 mm; p < 0.01) diameters were documented. Moreover, a significant improvement in heart failure symptoms (NYHA class 3.4 ± 0.6 vs. 1.5 ± 0.7; p < 0.01) was also observed. CONCLUSION: Targeted antibiotic treatment of Bb-related recent-onset DCM in addition to conventional heart failure therapy is associated with favorable cardiac remodeling and improvement of heart failure symptoms.
- 650 _2
- $a antibakteriální látky $x aplikace a dávkování $7 D000900
- 650 _2
- $a Borrelia burgdorferi $x izolace a purifikace $7 D025065
- 650 _2
- $a dilatační kardiomyopatie $x diagnóza $x farmakoterapie $x mikrobiologie $7 D002311
- 650 _2
- $a kardiotonika $x aplikace a dávkování $7 D002316
- 650 _2
- $a ceftriaxon $x aplikace a dávkování $7 D002443
- 650 _2
- $a kombinovaná farmakoterapie $x metody $7 D004359
- 650 _2
- $a bakteriální endokarditida $x diagnóza $x farmakoterapie $x mikrobiologie $7 D004697
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a injekce intravenózní $7 D007275
- 650 _2
- $a lymeská nemoc $x diagnóza $x farmakoterapie $x mikrobiologie $7 D008193
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a klinické zkoušky kontrolované $7 D018848
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Palecek, Tomas $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic. tpalec@lf1.cuni.cz. International Clinical Research Center, St. Anne's University Hospital in Brno, Brno, Czech Republic. tpalec@lf1.cuni.cz.
- 700 1_
- $a Havranek, Stepan $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Vitkova, Ivana $u Institute of Pathology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Nemecek, Eduard $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Trckova, Radka $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Berenová, Dagmar $u The National Institute of Public Health, Prague, Czech Republic. $7 xx0210361
- 700 1_
- $a Krsek, Daniel $u The National Institute of Public Health, Prague, Czech Republic. $7 xx0210362
- 700 1_
- $a Podzimkova, Jana $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Fikrle, Michal $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic. $7 xx0322391
- 700 1_
- $a Danek, Barbara Anna $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic. $7 xx0313114
- 700 1_
- $a Linhart, Ales $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 773 0_
- $w MED00002031 $t Herz $x 1615-6692 $g Roč. 40, č. 6 (2015), s. 892-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25939436 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20240911144727 $b ABA008
- 999 __
- $a ok $b bmc $g 1155502 $s 945360
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 40 $c 6 $d 892-7 $e 20150505 $i 1615-6692 $m Herz $n Herz $x MED00002031
- LZP __
- $a Pubmed-20160722
